Kathy Yi is CFO & VP at SANGAMO THERAPEUTICS, INC (SGMO). They have made 15 open-market trades across 1 company since 2018, most recently 2019-05-15.
CIK 0001697802
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 15 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SGMO | 30,512 | $5K |
Shares reported on the most recent Form 4, priced at the 2019-05-17 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SGMO | SELL | 2019-05-15 | 2019-05-17 | $10.00 | $50K | -5.8% | -2.7% | +10.2% |
| SGMO | SELL | 2019-04-15 | 2019-04-16 | $12.11 | $61K | +0.5% | -13.6% | -0.2% |
| SGMO | SELL | 2019-03-15 | 2019-03-18 | $10.00 | $50K | -4.7% | +19.6% | -0.2% |
| SGMO | SELL | 2019-03-01 | 2019-03-05 | $10.00 | $50K | -3.1% | +20.8% | -11.6% |
| SGMO | SELL | 2019-01-15 | 2019-01-16 | $11.04 | $110K | -2.0% | -22.5% | +5.7% |
| SGMO | SELL | 2018-12-17 | 2018-12-18 | $11.44 | $57K | +3.8% | +2.1% | -11.4% |
| SGMO | SELL | 2018-11-15 | 2018-11-16 | $10.00 | $50K | +8.2% | +3.5% | -18.3% |
| SGMO | SELL | 2018-10-15 | 2018-10-16 | $13.97 | $70K | -10.4% | -29.4% | -25.0% |
| SGMO | SELL | 2018-09-17 | 2018-09-18 | $14.66 | $73K | +12.3% | -6.0% | -24.4% |
| SGMO | SELL | 2018-08-16 | 2018-08-17 | $15.39 | $77K | +8.7% | -4.9% | -32.9% |
| SGMO | SELL | 2018-07-16 | 2018-07-17 | $14.77 | $74K | -12.8% | +1.6% | -8.7% |
| SGMO | SELL | 2018-06-15 | 2018-06-15 | $15.67 | $78K | -9.7% | -7.4% | -4.8% |
| SGMO | SELL | 2018-05-15 | 2018-05-16 | $15.38 | $77K | -4.0% | -2.5% | +0.9% |
| SGMO | SELL | 2018-04-16 | 2018-04-18 | $19.83 | $198K | -18.1% | -17.4% | -21.5% |
| SGMO | SELL | 2018-03-15 | 2018-03-16 | $25.56 | $128K | -14.8% | -22.7% | -32.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.